Gray matter pathology in (chronic) MS: modern views on an early observation.
about
Clinical correlates of grey matter pathology in multiple sclerosisPositive or negative involvement of heat shock proteins in multiple sclerosis pathogenesis: an overviewGray matters in multiple sclerosis: cognitive impairment and structural MRI.An Observational Study to Assess Brain MRI Change and Disease Progression in Multiple Sclerosis Clinical Practice-The MS-MRIUS Study.Identification and clinical impact of multiple sclerosis cortical lesions as assessed by routine 3T MR imaging.Combining tractography and cortical measures to test system-specific hypotheses in multiple sclerosis.Gray matter imaging in multiple sclerosis: what have we learned?Theiler's virus infection: Pathophysiology of demyelination and neurodegeneration.White matter lesions and vascular cognitive impairment: part 1: typical and unusual causes.CLADA: cortical longitudinal atrophy detection algorithm.Shifting imaging targets in multiple sclerosis: from inflammation to neurodegeneration.MRI correlates of disability progression in patients with CIS over 48 months.The role of immune cells, glia and neurons in white and gray matter pathology in multiple sclerosis.Heterogeneity versus homogeneity of multiple sclerosis.Differentiation and quantification of inflammation, demyelination and axon injury or loss in multiple sclerosis.White and gray matter damage in primary progressive MS: The chicken or the egg?Modeling the relationship among gray matter atrophy, abnormalities in connecting white matter, and cognitive performance in early multiple sclerosis.Contribution of cortical lesion subtypes at 7T MRI to physical and cognitive performance in MS.The gray aspects of white matter disease in multiple sclerosis.Neuropathogenesis of Theiler's murine encephalomyelitis virus infection, an animal model for multiple sclerosisInflammation in neurodegenerative diseases.Mechanisms of neuronal dysfunction and degeneration in multiple sclerosis.FTY720 on the way from the base camp to the summit of the mountain: relevance for remyelination.Recent progress in omics-driven analysis of MS to unravel pathological mechanisms.Differential diagnosis of white matter lesions: Nonvascular causes-Part II.Significance of gray matter brain lesions in multiple sclerosis and neuromyelitis optica.Over-the-counter anti-oxidant therapies for use in multiple sclerosis: A systematic review.Ocrelizumab: a B-cell depleting therapy for multiple sclerosis.A Novel Semiautomated Pipeline to Measure Brain Atrophy and Lesion Burden in Multiple Sclerosis: A Long-Term Comparative Study.Imaging in multiple sclerosis: A new spin on lesions.Postmortem validation of MRI cortical volume measurements in MS.Brain Atrophy as a Measure of Neuroprotective Drug Effects in Multiple Sclerosis: Influence of Inflammation.The sphingosine 1-phosphate receptor agonist FTY720 is neuroprotective after cuprizone-induced CNS demyelination.Advances in understanding gray matter pathology in multiple sclerosis: are we ready to redefine disease pathogenesis?Influence of treatment in multiple sclerosis disability: an open, retrospective, non-randomized long-term analysis.Grey matter damage in progressive multiple sclerosis versus amyotrophic lateral sclerosis: a voxel-based morphometry MRI study.B-cell enrichment and Epstein-Barr virus infection in inflammatory cortical lesions in secondary progressive multiple sclerosis.Evolution of cortical and thalamus atrophy and disability progression in early relapsing-remitting MS during 5 years.Subcortical and cortical gray matter atrophy in a large sample of patients with clinically isolated syndrome and early relapsing-remitting multiple sclerosis.Gray matter trophism, cognitive impairment, and depression in patients with multiple sclerosis.
P2860
Q26999302-C48748F7-7B05-40C8-BAED-7BE2BC85D8B3Q27000682-47FE38B0-9ED0-4417-8306-2011569769E1Q30768942-57440BB1-0DE3-4AF7-873B-0F5D6897B502Q33697898-0691F80C-B27A-4748-9428-88ADA9D56EB7Q33817835-128C9FD9-DB71-4AE8-A956-C3403AA3D645Q34078413-2A532536-1D6C-4B6A-818E-BB1DEFB05BECQ34094761-B9B157EA-9CED-462F-9F4A-88510CEA97AFQ34118301-E9B985EA-48A6-4F89-9520-C31E3FAAA99CQ34156950-4D3EEBE0-0AE3-4D19-9268-819679D77D3BQ34245589-15AA43CE-32DD-4008-BDC9-EA1E24432780Q34303664-2757D765-6F8F-4770-98E7-AE3AEDFD87BFQ34431806-A7116E88-A260-4F5B-99D4-50D5EF5B317AQ34468304-214736AE-73D9-4C22-AFD8-993517F66C12Q34893931-5CD89B4F-6400-4A2C-812F-FA1B8CC41D24Q35529707-F4DEFBCB-C9D4-46BF-ABA5-E857BC42A5DDQ36516787-74D95041-4D48-43A2-B8B9-FDF8F9B984F0Q37109163-0302450B-C3A9-4193-919A-28CDBF5E6E24Q37178774-F438EDCB-9E88-4263-ABC7-F8AFA14F4C62Q37208525-B618D611-DE58-4D8D-8F65-D0DA703353BDQ37628560-F38FE44B-4268-441E-BB85-37DBBE6D39A1Q37766302-D3C539B1-28BF-4657-AE2A-77C028E92C1AQ37800214-2D82E8F6-D8E0-470F-B5E2-4BCEF34E7E53Q37989903-2511DD94-C943-4668-943B-7EE06F382CCBQ38140023-EF8D4302-733D-4150-BFAB-FE9FF183EC96Q38187363-A80F0CDC-F9CF-4AB9-9C95-249374295362Q38529196-E24A5596-55CC-441B-85C1-412F15205D54Q38569263-26C0B827-F42B-40DE-8541-154E0D8A2A57Q38665518-034586FD-7D38-45AF-B38C-54E91FAADD70Q38808604-41EEF3BE-2ECD-4376-BE08-2801AA77045AQ38910256-4C918024-F2FF-4089-8C8C-10A09623A9A8Q40870174-386B1E51-0393-4CCE-9493-42FF24F70A0CQ41490523-4AC0F686-C047-4D23-B7C9-A2365590EDFCQ41958515-4ACCB4BC-09F2-4C22-8227-8CB5A61E797CQ42564134-8CCE9CCC-E93A-4026-88F4-243CFF760D0FQ42929708-DF3F799A-3698-4391-AD95-3075F761807EQ44642567-FC12CD4E-151A-42E9-874B-D4DEB5BD1C07Q45353475-8828DDB6-B8B0-4A50-99F5-A81D5284F612Q46466612-A1CF5576-1D1D-4E87-8568-5350A1D09837Q47908989-50794B59-7B3B-4094-9E5E-3B82AC5B4DD6Q47975209-57C80273-3A3B-4F66-87DC-62607156C8B5
P2860
Gray matter pathology in (chronic) MS: modern views on an early observation.
description
2009 nî lūn-bûn
@nan
2009 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
Gray matter pathology in (chronic) MS: modern views on an early observation.
@ast
Gray matter pathology in (chronic) MS: modern views on an early observation.
@en
type
label
Gray matter pathology in (chronic) MS: modern views on an early observation.
@ast
Gray matter pathology in (chronic) MS: modern views on an early observation.
@en
prefLabel
Gray matter pathology in (chronic) MS: modern views on an early observation.
@ast
Gray matter pathology in (chronic) MS: modern views on an early observation.
@en
P2093
P1476
Gray matter pathology in (chronic) MS: modern views on an early observation.
@en
P2093
Jeroen J G Geurts
Peter K Stys
R Zivadinov
P356
10.1016/J.JNS.2009.01.018
P577
2009-02-26T00:00:00Z